Clinical trials
Observational Proteinuria trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2018 | 1 |
| 2021 | 2 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Recruiting | 3 |
| Unknown status | 2 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 6 |
| Progenity, Inc. | 2 |
| University of Alabama at Birmingham | 2 |
| University of Mississippi Medical Center | 2 |
| Amicus Therapeutics | 1 |
| Beth Israel Deaconess Medical Center | 1 |
| Children's Hospital of Philadelphia | 1 |
| Indiana University | 1 |
| MemorialCare | 1 |
| MemorialCare Health System | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Proteinuria | 28 |
| Kidney Diseases | 8 |
| Renal Insufficiency, Chronic | 7 |
| Hypertension | 6 |
| Pre-Eclampsia | 5 |
| Glomerulosclerosis, Focal Segmental | 4 |
| Renal Insufficiency | 4 |
| Fabry Disease | 3 |
| Nephrotic Syndrome | 3 |
| Acute Kidney Injury | 2 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.